Roche Looks To Real World Data And IT To Drive China Partnering
Mark Noguchi, Global Head, Alliance and Asset Management at Roche, outlines to Scrip’s Brian Yang the Swiss group's plans to tap into the emerging IT expertise and partnering opportunities in China.
You may also be interested in...
As Chinese returnees transform their startups to fully-fledged biopharma operations with a full product lineup and the global market in sight, the journey has been filled with challenges. Based on interviews and on-the-ground reporting, this new series takes a closer look at several companies' experiences.
Regulatory pressure to fully approve the first COVID-19 vaccine in China is mounting as top officials tour an inspection agency and two leading manufacturers.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.